Treatment patterns and comorbid burden of patients newly diagnosed with multiple sclerosis in the United States.
David M KernM Soledad CepedaPublished in: BMC neurology (2020)
Approximately two-thirds of patients newly diagnosed with MS did not receive a DMT and the disease is accompanied by a significant comorbid burden.